Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Douglas D, Richardson"'
Autor:
Laurence Whitty-Léveillé, Zachary L. VanAernum, Jorge Alexander Pavon, Christa Murphy, Katie Neal, William Forest, Xinliu Gao, Wendy Zhong, Douglas D. Richardson, Hillary A. Schuessler
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTTransition metals can be introduced in therapeutic protein drugs at various steps of the manufacturing process (e.g. manufacturing raw materials, formulation, storage), and can cause a variety of modifications on the protein. These modificati
Externí odkaz:
https://doaj.org/article/e85c42b380f64a3e848c113be5ed8715
Autor:
Xuanwen Li, Nicholas A. Pierson, Xiaoqing Hua, Bhumit A. Patel, Michael H. Olma, Christopher A. Strulson, Simon Letarte, Douglas D. Richardson
Publikováno v:
Journal of Pharmaceutical Sciences. 112:691-699
The use of multi-attribute method (MAM) for identity and purity testing of biopharmaceuticals offers the ability to complement and replace multiple conventional analytical technologies with a single mass spectrometry (MS) method. Phase-appropriate me
Autor:
Alexander Graf, Angus Woodhams, Michael Nelson, Douglas D. Richardson, Steven M. Short, Mark Brower, Marek Hoehse
Publikováno v:
Sensors, Vol 22, Iss 9, p 3397 (2022)
Raman spectroscopy is an analytical technology for the simultaneous measurement of important process parameters, such as concentrations of nutrients, metabolites, and product titer in mammalian cell culture. The majority of published Raman studies ha
Externí odkaz:
https://doaj.org/article/7a900191ccdc414da3861215fc0f76a4
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
The success of monoclonal antibody (mAb) therapeutics have increased pharmaceutical investment in mAb production, which has led to a greater demand of technologies to efficiently characterize these biotherapeutics. The large size and heterogeneity of
Externí odkaz:
https://doaj.org/article/06b9363b187149d795c4f4cf0af26491
Autor:
Simon Letarte, Li-Kang Zhang, Douglas D. Richardson, Rong-Sheng Yang, Damon Barbacci, Nick DeGraan-Weber, David R. Bush
Publikováno v:
Journal of Pharmaceutical Sciences. 111:314-322
The commercially available Polysorbate 80 (PS-80) is a highly heterogeneous product. It is a complex and structurally diverse mixture consisting of polymeric species containing polyoxyethylenes (POEs), fatty acid esters, with/or without a carbohydrat
Publikováno v:
Antibody Therapeutics. 5:42-54
Nonionic surfactant polysorbates, including PS-80 and PS-20, are commonly used in the formulation of biotherapeutic products for both preventing surface adsorption and acting as stabilizer against protein aggregation. Trace levels of residual host ce
Autor:
Nicole M. Ralbovsky, Randal J. Soukup, Justin P. Lomont, Mackenzie L. Lauro, Amanda Gulasarian, Anumita Saha-Shah, Michael A. Winters, Douglas D. Richardson, Sheng-Ching Wang, Ian Mangion, Joseph P. Smith
Publikováno v:
The Analyst. 147:378-386
Process analytical technology was used to monitor formation of a stable emulsion product, with results providing improved understanding of emulsion-based vaccine adjuvant formation processes.
Publikováno v:
Multi-Dimensional Liquid Chromatography ISBN: 9781003090557
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e877c89e8225adc0876e5edd191029f
https://doi.org/10.1201/9781003090557-10
https://doi.org/10.1201/9781003090557-10
Autor:
Irina Perdivara, Ben Niu, Kim F. Haselmann, St John Skilton, Anthony Leone, Gregory O. Staples, Carsten P. Sønksen, Helena Maria Barysz, Andrew Hanneman, Chun Shao, Rebecca Scott, Anders Lund, Carly Daniels, Michael Jahn, Da Ren, Nunzio Sepe, K. Ilker Sen, Zoran Sosic, David Ripley, Jing Zhen, Margo Wilson, Melissa Alvarez, John G Hoogerheide, Xinbi Li, Harini Kaluarachchi, Josh Woods, Wenqin Ni, Albrecht Gruhler, Keith A. Johnson, Arnd Brandenburg, Kristen Nields, Michelle Busch, Douglas D. Richardson, Yan Wang, Ahmet Cansizoglu, Xiaoxiao Li, Greg W Adams, Simon Letarte, Joe Shambaugh, Hua Yuan, Trina Mouchahoir, Tom Robinson, Xiaoshi Wang, Nancy S. Nightlinger, Alexander Julian Veach, Chris Chumsae, Eric Carlson, Dongdong Wang, Sean Shen, Jing Fang, Wei Wu, Stefano Gotta, Justin B. Sperry, Hirsh Nanda, X. Christopher Yu, Sibylle Heidelberger, Bhumit A. Patel, Jihong Wang, Sean McCarthy, Himakshi Patel, Thomas N. Krogh, Hunter Walker, Olga V. Friese, Daniela Tizabi, Yali Lu, Kristin Boggio, Ernest L. Maynard, Rich Rogers, Ying Zhou, Nick DeGraan-Weber, John E. Schiel, Weibin Chen, Jason C. Rouse, Li Tao, Thomas W. Powers, John Kim, Xu Guo, Bo Yan, Gabriella Leo, Ying Zhang, Oleg V. Borisov, Ying Qing Yu, Martha Stapels, Wael Yared, Yan-Hui Liu, Alan Heckert, Sarah Rogstad, Li Zang, Aaron Ammerman, Li Cao, Benjamin J. Place, Richard Ludwig, Anton V. Manuilov, Andrew Mahan, Andrew Dawdy, Yi Wang, Brian Schmidt, Peiran Liu
Publikováno v:
Journal of the American Society for Mass Spectrometry. 32:913-928
The Multi-Attribute Method (MAM) Consortium was initially formed as a venue to harmonize best practices, share experiences, and generate innovative methodologies to facilitate widespread integration of the MAM platform, which is an emerging ultra-hig
Autor:
Xuanwen Li, Nicholas A. Pierson, Xiaoqing Hua, Bhumit A. Patel, Michael H. Olma, Christopher A. Strulson, Simon Letarte, Douglas D. Richardson
The use of Multi-attribute method (MAM) for identity and purity testing of biopharmaceuticals offers the ability to complement and replace multiple conventional analytical technologies with a single mass spectrometry (MS) method. Method qualification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b8c5b8cc24a26e2e9271085bbd3f93
https://doi.org/10.1101/2022.05.01.490194
https://doi.org/10.1101/2022.05.01.490194